Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass

European Journal of Cardio-thoracic Surgery

Volumn 26, Issue 2, 2004, Pages 289-293

  Tabata, Shigeki ^a   Yamaguchi, Syohjiro ^a   Nagamine, Hiroshi ^a   Tomita, Shigeyuki ^a   Arai, Sadahiko ^a   Takemura, Hirofumi ^a   Watanabe, Go ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiopulmonary bypass; Glycoprotein IIb IIIa antagonist; Platelet; Platelet anesthesia

Indexed keywords

4 (4 AMIDINOPHENOXY)BUTYRYLASPARTYLVALINE; ADENOSINE DIPHOSPHATE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; DOG; DRUG EFFICACY; MEDICAL ASSESSMENT; NONHUMAN; OXYGENATOR; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPECIES COMPARISON; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADENOSINE DIPHOSPHATE; ANIMALS; BLOOD PLATELETS; CARDIOPULMONARY BYPASS; DIPEPTIDES; DOGS; MICROSCOPY, ELECTRON, SCANNING; OXYGENATORS; PLATELET AGGREGATION; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE HEMORRHAGE; THROMBOCYTOPENIA; TIME FACTORS;

EID: 3543134181     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2004.03.036     Document Type: Article

References (18)

1. Woodman R.C., Harker L.A. Bleeding complications associated with cardiopulmonary bypass. Blood. 76:1990;1680-1697
2. Weerasinghe A., Taylor K.M. The platelet in cardiopulmonary bypass. Ann Thorac Surg. 66:1998;2145-2152
3. Hiramatsu Y., Gikakis N., Anderson H.L. III, Gorman J.H. III, Marcinkiewicz C., Gould R.J., Niewiarowski S., Edmunds L.H. Jr. Tirofiban provides platelet anesthesia during cardiopulmonary bypass in baboons. J Thorac Cardiovasc Surg. 113:1997;182-193
4. Addonizio V.P., Strauss J.F., Macarak E.J., Colman R.W., Edmunds L.H. Jr. Preservation of platelet number and function with prostaglandin E1 during total cardiopulmonary bypass in rhesus monkeys. Surgery. 83:1978;619-625
5. Teoh K.H., Christakis G.T., Weisel R.D., Wong P.Y., Mee A.V., Ivanov J., Madonik M.M., Levitt D.S., Reilly P.A., Rosenfeld J.M., Glynn M.F.X. Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 96:1988;332-341
6. Kappa J.R., Fisher C.A., Todd B., Stenach N., Bell P., Campbell F., Ellison N., Addonizio V.P. Intraoperative management of patients with heparin-induced thrombocytopenia. Ann Thorac Surg. 49:1990;714-722
7. De Prost D., Barbier-Boehm G., Hazebroucq J., Ibrahim H., Bielsky M.C., Hvass U., Lacombe C., Francais J.L., Desmonts J.M. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thromb Haemost. 68:1992;106-110
8. Gluszko P., Rucinski B., Musial J., Wenger R.K., Schmaier A.H., Colman R.W., Edmunds L.H. Jr., Niewiarowski S. Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit. Am J Physiol. 252:1987;H615-H621
9. Musial J., Niewiarowski S., Rucinski B., Stewart G.J., Cook J.J., Williams J.A., Edmunds L.H. Jr. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Circulation. 82:1990;261-273
10. Carteaux J.P., Roux S., Kuhn H., Tschopp T., Colombo V., Hadvary P. Ro 44-9883, a new nonpeptide glycoprotein IIb/IIIa antagonist, prevents platelet loss during experimental cardiopulmonary bypass. J Thorac Cardiovasc Surg. 106:1993;834-841
11. Uthoff K., Zehr K.J., Geerling R., Herskowitz A., Cameron D.E., Reitz B.A. Inhibition of platelet adhesion during cardiopulmonary bypass reduces postoperative bleeding. Circulation. 90:1994;II269-II274
12. Aoki T., Cox D., Senzaki K., Seki J., Tanaka A., Takasugi H., Motoyama Y. The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIB/IIIA antagonist. Thromb Res. 81:1996;439-450
13. Butler J., Rocker G.M., Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 55:1993;552-559
14. Khuri S.F., Valeri C.R., Loscalzo J., Weinstein M.J., Birjiniuk V., Healey N.A., MacGregor H., Doursounian M., Zolkewitz M.A. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg. 60:1995;1008-1014
15. Wenger R.K., Lukasiewicz H., Mikuta B.S., Niewiarowski S., Edmunds L.H. Jr. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg. 97:1989;235-239
16. Menys V.C., Belcher P.R., Noble M.I., Evans R.D., Drossos G.E., Pillai R., Westaby S. Macroaggregation of platelets in plasma, as distinct from microaggregation in whole blood (and plasma), as determined using optical aggregometry and platelet counting, respectively, is specifically impaired following cardiopulmonary bypass in man. Thromb Haemost. 72:1994;511-518
17. Ashmore P.G., Svitek V., Ambrose P. The incidence and effects of particulate aggregation and microembolism in pump-oxygenator systems. J Thorac Cardiovasc Surg. 55:1968;691-697
18. Suzuki Y., Hillyer P., Miyamoto S., Niewiarowski S., Sun L., Rao A.K., Hollenbach S., Edmunds L.H. Jr. Integrilin prevents prolonged bleeding times after cardiopulmonary bypass. Ann Thorac Surg. 66:1998;373-381